.Novo Nordisk is proceeding its press right into hereditary medicines, accepting to pay NanoVation T...
.Innovent Biologics has helped make the case that its own gate inhibitor-cytokine fusion healthy pro...
.A period 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate ...
.5 months after Rakovina Rehabs turned towards artificial intelligence, the cancer-focused biotech h...
.Ascendis Pharma has become a prospective risk to BioMarin's Voxzogo, reporting stage 3 growth disor...
.Though Alkeus Pharmaceuticals' dental eye condition possession failed to substantially lower geogra...
.With a triad of biotechs hitting the Nasdaq on Friday, it was actually easy to miss a smaller-scale...
.Invulnerable checkpoint preventions are actually the superheroes of cancer therapy. Medicines like ...
.Welcome to recently's Chutes & Ladders, our summary of notable leadership hirings, firings and r...
.Regeneron is back with long-term follow-up for its own LAG-3 prevention and PD-1 prevention combo i...